ACHN—With the release of today’s monotherapy data (#msg-109273133), another HCV canard can be laid to rest: ACH-3422 is not a turbocharged version of Sovaldi.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.